We are exclusively focused on vascular access and medication management.
Spectrum Vascular offers a diverse portfolio of vascular access devices that leverage our best-in-class SV Spectrum™ and SV BioFlo technologies to address the most common and costly vascular access complications.
Rely on proven CLABSI and CRBSI prevention technology validated by over 30 peer-reviewed studies and meta-analysis.1-38
Minimize platelet aggregation leading to occlusions with disruptive technology that is present throughout the catheter shaft and is present for the life of the catheter.
Rethink cost by reducing infections and complications —
~$45k to treat one single CRBSI case and ~$16k impact of a single UEDVT.23-28
Reimagine your choices and provide better patient experience.
SV Spectrum™ Technology*
Our SV Spectrum catheters are impregnated with minocycline and rifampin (M+R), providing protection against CLABSI and CRBSIs.
*Currently branded and sold as Cook Spectrum MR technology.
SV BioFlo Technology
Our SV BioFlo catheters are made with Endexo® technology — a surface modifying macromolecule — to reduce thrombus accumulation and thrombus related catheter complications.
*Endexo is a registereted trademark of Interface Biologics, Inc.
Comprehensive: Arterial Pressure Monitoring Sets & Trays
Adults: Arterial Pressure Monitoring Sets & Trays
Pediatric: Arterial Pressure Monitoring Sets & Trays
Scientific Research & Publications
Better Health Care is Our Mission
Interested in the Spectrum Vascular portfolio? Let’s talk.